Rick Liao
Impact in
-
- Parkinson's Disease Mechanisms and Treatments
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 2
- Genomics and Phylogenetic Studies 2
- S100 Proteins and Annexins 1
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Elizabeth Nance (7 shared papers)Vineeth Chandran Suja (3 shared papers)Samir Mitragotri (3 shared papers)Thomas R. Wood (3 shared papers)Zongmin Zhao (1 shared paper)Lydia M. Contreras (2 shared papers)Mengying Zhang (2 shared papers)Michael J. Palumbo (1 shared paper)
- Journals
- Bioengineering & Translational Medicine (2 papers)Nature Communications (1 paper)Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (1 paper)AIChE Journal (1 paper)Biointerphases (1 paper)
- Partner nations
- United StatesNorway
In The Last Decade
Rick Liao
11 papers receiving 346 citations
Rick Liao's Hit Papers
Peers
Comparison fields: 5 of 92
- Neurology 34
- Neurology 47
- Biomaterials 31
- Molecular Biology 153
- Biological Psychiatry 5
Countries citing papers authored by Rick Liao
This map shows the geographic impact of Rick Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Liao more than expected).
Fields of papers citing papers by Rick Liao
This network shows the impact of papers produced by Rick Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Liao. The network helps show where Rick Liao may publish in the future.
Co-authors
The 21 scholars most cited alongside Rick Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Alzheimer's and Parkinson's disease therapies in the clinic Hit paper breakdown → | 2022 | 117 |
| 2 | 2014 | 42 | |
| 3 | 2014 | 34 | |
| 4 | 2023 | 30 | |
| 5 | 2020 | 28 | |
| 6 | 2016 | 27 | |
| 7 | 2020 | 21 | |
| 8 | 2020 | 21 | |
| 9 | 2020 | 20 | |
| 10 | 2017 | 5 | |
| 11 | 2021 | 2 | |
| 12 | 2025 | 0 |
About Rick Liao
Rick Liao is a scholar working on Molecular Biology, Biomaterials, Neurology, Biomedical Engineering and Organic Chemistry, having authored 12 papers that have together received 347 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers), RNA Interference and Gene Delivery (2 papers), Genomics and Phylogenetic Studies (2 papers), Alzheimer's disease research and treatments (1 paper), Neuroscience and Neural Engineering (1 paper), Hydrogen's biological and therapeutic effects (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Neurology (34 citations), Neurology (47 citations), Biomaterials (31 citations), Molecular Biology (153 citations) and Biological Psychiatry (5 citations). Rick Liao has collaborated with scholars based in United States and Norway. Frequent co-authors include Elizabeth Nance, Vineeth Chandran Suja, Samir Mitragotri, Thomas R. Wood, Zongmin Zhao, Lydia M. Contreras, Mengying Zhang, Michael J. Palumbo, Kolade Adebowale and Neha Kapate. Their work appears in journals such as Bioengineering & Translational Medicine, Nature Communications, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, AIChE Journal and Biointerphases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.